
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79376 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Palonosetron Related Compound E (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
CAS:Lactams, nesoiFormula:C19H22N2O·HClColor and Shape:Yellow SolidMolecular weight:330.14989Apixaban
CAS:Lactams, nesoiFormula:C25H25N5O4Color and Shape:Off-White White SolidMolecular weight:459.19065Paliperidone Related Compound B (6-fluoro-3-(piperidin-4-yl)benzoisoxazole hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H13FN2OColor and Shape:White PowderMolecular weight:220.10119Tacrolimus 8-epimer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C44H69NO12Color and Shape:White PowderMolecular weight:803.48198Bosentan Related Compound E (4-(tert-butyl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C10H15NO2SColor and Shape:PowderMolecular weight:213.08235Capecitabine Related Compound A (5'-deoxy-5-fluorocytidine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C9H12FN3O4Color and Shape:Off-White PowderMolecular weight:245.08118Tolcapone Related Compound A (4'-methyl-3,4-dihydroxybenzophenone)
Ketone-phenols and ketones with other oxygen functionFormula:C14H12O3Color and Shape:Off-White PowderMolecular weight:228.24Sulfamethoxazole Related Compound B (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C16H16N4O5S2Color and Shape:Off-White White PowderMolecular weight:408.05621Bendamustine Related Compound A (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H23N3O4HClColor and Shape:White SolidMolecular weight:357.83Triclosan Related Compounds Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:Colorless Clear LiquidZoledronic Acid Related Compound A (2-(1H-Imidazol-1-yl)acetic acid)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C5H6N2O2Color and Shape:White PowderMolecular weight:126.04293Methylphenidate Hydrochloride Erythro Isomer Solution
CAS:Controlled ProductCompounds containing an unfused pyridine ring in the structure, nesoiFormula:C14H19NO2·HClColor and Shape:Clear LiquidMolecular weight:269.11826Methyl 12-Hydroxystearate
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormula:C19H38O3Color and Shape:White Off-White PowderMolecular weight:314.2821Nefazodone Related Compound B (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or notFormula:C25H32ClN5O2·HClColor and Shape:White PowderMolecular weight:506.47Citalopram Related Compound E (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C20H21FN2O2·HClColor and Shape:White PowderMolecular weight:340.15871Econazole Related Compound B (2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine nitrate)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C15H14Cl3NO·HNO3Color and Shape:White PowderMolecular weight:329.0141Ramipril Related Compound D (Ethyl (S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C23H30N2O4Color and Shape:White PowderMolecular weight:398.22056Acetaldehyde
CAS:Ethanal (acetaldehyde)Formula:C2H4OColor and Shape:Clear Colorless LiquidMolecular weight:44.02621Sevoflurane Related Compound C (1,1,1,3,3,3-hexafluoro-2-propanol)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives of acyclic alcohols, nesoi (excluding ethchlorovynol [inn])Formula:C3H2F6OColor and Shape:Clear Colorless LiquidMolecular weight:168.00098Lovastatin Epimer Mixture (Epilovastatin and Lovastatin 1:1 Mixture)
Lactones nesoiFormula:C24H36O5Color and Shape:PowderMolecular weight:404.25627

